DOI: https://dx.doi.org/10.18203/2320-1770.ijrcog20221435
Published: 2022-05-26

A comparative study of antenatal and fetal complications in pregnant women with and without history of polycystic ovary syndrome

Suman Meghwal, Lata Rajoriya, Ambika Shankar, Rupal Malik, Sunita Dhaka

Abstract


Background: Polycystic ovary syndrome in the present generation is a very common reproductive disorder and the prevalence is on the rise. Aim of the current study was to compare the maternal outcome in normal and women with PCOS.

Methods: This study was a case-control study conducted in Department of Obstetrics and Gynaecology, SMS Medical College and attached group of hospitals, Jaipur from May 2019 to August 2020. Pregnant women with history of PCOS were taken as cases and with no such history were controls.

Results: 9.49% women developed gestational diabetes mellitus (GDM) in cases as compared to 1.61% women in control group. The difference in the incidence of GDM in the two groups was statistically significant. When hypertensive disorders of pregnancy were considered, a statistically significant difference was observed as 11.2% cases and 2.42% controls showed HDP. Mean birth weight of neonate in cases was 2.43±0.31 kg and in control group was 2.71±0.29 kg. Mean APGAR score at 1 minute in cases was 6.21±1.23 and in controls was 7.21±0.24. APGAR score at 5 minutes in PCOS group was 7.89±1.40 and in control group was 8.12±0.21. 12 neonates from the cases group were admitted in NICU. The difference was statistically significant when compared

Conclusions: With a detailed comparative analysis of this case-control study, it can be concluded that many antenatal and fetal complications are per se increased in women with a history of PCOS.


Keywords


Diabetes, HDP, PCOS, NICU, APGAR, Birth weight

Full Text:

PDF

References


Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol. 2011;24(4): 223-7.

Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam G, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific; 1992.

Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-7.

Palomba S, de Wilde MA, Falbo A, Koster MPH, Sala GBL, Fauser BCJM. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod. 2015;21(5):575-92.

Sha T, Wang X, Cheng W, Yan Y. A meta-analysis of pregnancy-related outcomes and complications in women with polycystic ovary syndrome undergoing IVF. Reprod Biomed. 2019;39(2):281-93.

Urman B, Sarac E, Dogan L, Gurgan T. Pregnancy in infertile PCOD patients. Complications and outcome. J Reprod Med. 1997;42:501-5.

Toulis KA, Goulis DG, Kolibianakis EM, Venetis CA, Tarlatzis BC, Papadimas I. Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: A systematic review and a meta-analysis. Fertil Steril. 2009;92:667-77.

Veltman-Verhulst SM, van Haeften TW, Eijkemans MJC, de Valk HW, Fauser BC, Goverde AJ. Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome. Hum Reprod. 2010;25:3123-8.

Diamant YZ, Rimon E, Evron S. High incidence of preeclamptic toxemia in patients with polycystic ovarian disease. Eur J Obstet Gynecol Reprod Biol. 1982;14:199-204.

de Vries MJ, Dekker GA, Schoemaker J. Higher risk of preeclampsia in the polycystic ovary syndrome: A case control study. Eur J Obstet Gynecol Reprod Biol. 1998;76:91-5.

Radon PA, McMahon MJ, Meyer WR. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol. 1999;94:194-7.

Kjerulff LE, Sanchez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: A metaanalysis. Am J Obstet Gynecol. 2011;204:558.

Naver KV, Grinsted J, Larsen SO, Hedley PL, Jorgensen FS, Christiansen M, Nilas L. Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia. BJOG. 2014;121(5):575-81.

McDonnel R, Hart RJ. Pregnancy-related outcomes for women with polycystic ovary syndrome. Women's Health. 2017;13(3):89-97.

Roos N, Kieler H, Sahlin L, Ekman-Ordeberg G, Falconer H, Stephansson O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: Population based cohort study. BMJ. 2011;343:6309

Lovvik TS, Wikstrom A-K, Neovius M, Stephansson O, Roos N, Vanky E. Pregnancy and perinatal outcomes in women with polycystic ovary syndrome and twin births: a population-based cohort study. BJOG. 2015;122:1295-302.

Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod. 2001;16: 226-9.